News Summary: Nutrition sale boosts Pfizer 4Q net

News Summary: Drugmaker Pfizer's 4Q net surges on $4.8B gain from sale of nutrition business

Associated Press

STRONG RESULTS: Pfizer Inc. posted sharply higher fourth-quarter net income as tight spending controls and a huge gain from selling its nutrition business helped offset sharply lower sales of cholesterol fighter Lipitor.

THE NUMBERS: Pfizer reported net income of $6.3 billion, or 85 cents a share. Revenue fell 7 percent at $15 billion, hurt by generic rivals to Lipitor and other prescription drugs.

BETTER THAN EXPECTED: Excluding the windfall from selling its nutrition business to Nestle SA for $11.5 billion on Nov. 30, and a total of $888 million for restructuring, legal and other one-time items, the Viagra maker would have had a profit of $3.51 billion, or 47 cents per share. That's 3 cents more than analysts surveyed by FactSet were expecting.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You